Detalhe da pesquisa
1.
The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012-2019.
BMC Infect Dis;
22(1): 775, 2022 Oct 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36199012
2.
The Comparative Effectiveness of Ceftolozane/Tazobactam versus Aminoglycoside- or Polymyxin-Based Regimens in Multi-Drug-Resistant Pseudomonas aeruginosa Infections.
Antibiotics (Basel);
11(5)2022 May 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35625270
3.
Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life.
J Patient Rep Outcomes;
6(1): 49, 2022 May 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35567724
4.
Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study.
Open Forum Infect Dis;
7(4): ofaa097, 2020 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32363211